ACCESS THE PCR LONDON VALVES 2025 REPLAYS

PCR London Valves On-demand

ARE YOU READY for what's next in storke prevention?

Thank you for your interest in PCR London Valves 2025!

At PCR London Valves, Boston Scientific was dedicating its full focus to Left Atrial Appendage Closure (LAAC) Therapy. Attendees have engaged in dynamic, peer-led discussions at the booth, including insightful conversations with leading experts in the field. Also, If you missed our two important symposia on November 17th! Watch out the Replay now.

Sign-up for full Replay

The Next Frontier in LAAC: Innovations and Opportunities

Anchorperson: Marek Grygier​

Spokesperson: Nina Wunderlich​

Discussants: Carsten Skurk, Ignacio Cruz-Gonzalez, Jan Kovac, Sergio Berti, Lorenz Räber​

​Learning objectives:​

  • Review the latest data on WATCHMAN FLX Pro and VersaCross Connect HEAL LAA and sub-analysis.​
  • Learn workflow strategies to improve efficiencies for LAAC: VersaCross Connect, WATCHMAN FLX Pro & TruSteer.​
  • Discuss the upcoming new clinical trials: CHAMPION AF and LAAOS IV.
Sign-up for full replay

LAA Closure is Evolving: Are You Ready?

Anchorperson: Jens Erik Nielsen-Kudsk​

Spokesperson: John Camm​

Discussants: Kasper Korsholm, Philippe Garot, Apostolos Tzikas​

​Learning objectives​

  • Recognize the unmet needs in stroke prevention for patients with atrial fibrillation.​
  • Interpret the latest clinical evidence and guideline recommendations on left atrial appendage closure.​
  • Identify patient populations who derive the greatest benefit from left atrial appendage closure.
Sign-up for full replay

Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.